Kendle Makes Major Play with Acquisition of Phase I Company DecisionLine
In a deal worth upwards of $24 million, Cincinnati, Ohio-based contract research organization (CRO) Kendle has boosted its early stage capabilities with the acquisition of DecisionLine, a central nervous system (CNS)-focused phase I company located in Toronto.
INC Research Creates New Division for Women’s Health Research
Raleigh, N.C.-based CRO INC Research launched its women’s health division to address the diverse challenges associated with female-related health issues, and to meet the escalating need to increase the enrollment of women in trials across all therapeutic areas.
Other breaking news...
Simcyp wins contract with Johnson & Johnson Pharmaceutical Research and Development... Perceptive Informatics and Digisonics team up in platform integration effort...
Company Profile: An interview with Anders Sørensen, business development manager, Cyncron A/S
